Publisher: Bentham Science Publishers
E-ISSN: 1875-5933|3|1|97-104
ISSN: 1568-010X
Source: Current Drug Targets. Inflammation & Allergy, Vol.3, Iss.1, 2004-03, pp. : 97-104
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Modulation of Th1 and Th2 responses for immunotherapy
Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 3, 2002-03 ,pp. :
By Yoshimura T. Nagao T. Nakao T. Watanabe S. Usami E. Kobayashi J. Yamazaki F. Tanaka H. Inagaki N. Nagai H.
General Pharmacology, Vol. 30, Iss. 2, 1998-02 ,pp. :
The therapeutic potential of regulation of the Th1/Th2 balance
By Rook G.
Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. :
Regulation of Angiogenesis by Th1- and Th2-Type Cytokines
Current Pharmaceutical Design, Vol. 9, Iss. 7, 2003-03 ,pp. :
Inflammation & Allergy-Drug Targets (Formerly Current Drug Targets - Inflammation & Allergy), Vol. 7, Iss. 2, 2008-06 ,pp. :